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Baker-Polito Administration Releases 2017 Third Quarterly Report on 
Opioid Epidemic  
Opioid-related overdose deaths fell 10 percent in first nine months of 2017 vs. same 
period last year 
 
BOSTON— Opioid-related overdose deaths in Massachusetts declined by an 
estimated 10 percent in the first nine months of this year compared to the first nine 
months of 2016, according to the third quarterly opioid-related overdose deaths 
report of 2017 released today by the Massachusetts Department of Public Health 
(DPH). It is the second consecutive quarterly report estimating a decline in the 
number of opioid-related overdose deaths. The report also found that the 
percentage of opioid-related overdoses that have resulted in deaths has decreased 
year over year.  
 
``This new report shows some trend lines that are moving in the right direction as we 
work to fight the opioid and heroin epidemic in Massachusetts, but there are still too 
many people dying from overdoses,’’ said Governor Charlie Baker. ``Our 
administration will continue efforts to combat this public health epidemic that is 
devastating families in every corner of the Commonwealth, and looks forward to 
introducing new proposals in the near future and working with the Legislature to 
pass meaningful reform to strengthen our efforts from prevention to recovery.”  
 
According to the report, fentanyl continues to be a major factor fueling the opioid 
crisis. The rate of fentanyl present in the toxicology of opioid-related overdose 
deaths continues to rise, reaching 81 percent this year, while the rate of prescription 
  
opioids and heroin present in opioid-related overdose deaths continues to decline. 
 
``Stemming the tide of this opioid epidemic is a massive undertaking and it will take 
time to address the suffering that underlies addictions,’’ said Health and Human 
Services Secretary Marylou Sudders. ``We continue to focus on a strong public 
health approach of prevention, intervention, treatment, and recovery and to 
strengthen the treatment system.’’ 
 
Selected Findings from the 2017 Q3 Report on Opioid-Related Deaths 
 The total number of estimated and confirmed deaths in the first nine months 
of 2017 is 1,470, which is 167 fewer deaths than the 1,637 estimated and 
confirmed deaths in the first nine months of 2016. This represents a 10 
percent decrease. (The previous report, released in August, showed an 
estimated 5 percent decline in opioid-related overdose deaths in the first six 
months of 2017 compared to the first six months of 2016, or 53 fewer 
deaths.) 
 
 The percentage of opioid-related overdoses that have resulted in deaths has 
decreased year over year. For example, the estimated opioid-related 
overdose death rate in 2016 increased by 21 percent from 2015; there was a 
32 percent increase in 2015 from the prior year; and in 2014, there was a 40 
percent increase from 2013.   
 
 The rate of fentanyl present in the toxicology of opioid-related deaths 
continues to rise and reached 81 percent in 2017, while the rate of heroin or 
likely heroin present in opioid-related deaths continues to decline. 
 
 The percentage of opioid-related overdose deaths where prescription drugs 
were present has trended downward since the beginning of 2014, when 
approximately a quarter of these deaths with a toxicology screen showed 
evidence of a prescription opioid. In the second quarter of 2017, prescription 
opioids were present in about 16 percent of opioid-related overdose deaths 
where a toxicology result was available. 
 
 In the third quarter of 2017 there were approximately 595,000 Schedule II 
opioid prescriptions reported to the Massachusetts Prescription Monitoring 
Program, just over a 29 percent decrease from the first quarter of 2015 when 
there were 841,990 Schedule II opioid prescriptions. 
 
 Approximately 271,000 people in Massachusetts received prescriptions for 
Schedule II opioids in the third quarter of 2017, which is 30 percent less than 
the first quarter of 2015, when there were 390,532 individuals receiving 
Schedule II opioids. 
 
 In the first six months of 2017, the greatest number of suspected opioid-
related overdoses treated by Emergency Medical Services is among males 
aged 25-34, accounting for 27 percent of opioid-related overdose incidents 
with a known age and gender.   
 
 The confirmed opioid-related overdose death rate for Hispanics doubled in 
three years from 15.8 opioid-related overdose deaths per 100,000-population 
in 2014 to 31.5 opioid-related overdose deaths per 100,000-population in 
2016, a nearly 100 percent increase.  
 
 The number of confirmed opioid-related overdose deaths for 2016 is updated 
to 2,094. 
 
 The number of confirmed opioid-related overdose deaths for 2015 is updated 
to 1,687. 
 
Public Health Commissioner Monica Bharel, MD, MPH, said having access to timely 
data provided in the quarterly reports allows for a more immediate public health 
response to the epidemic. ``The data in these quarterly reports, and in our other 
reports, help us to understand the arc of this epidemic and respond effectively to the 
areas of the greatest need.’’ 
 
Since the beginning of the opioid epidemic, the Baker-Polito Administration has 
increased annual spending for substance misuse prevention and treatment by 50 
percent not including MassHealth initiatives that expand access to residential 
treatment and evidence-based care for the state’s most vulnerable populations.   
Massachusetts led the nation in limiting first-time opioid prescriptions to seven days 
and revamped its prescription monitoring system, requiring prescribers to use the 
Massachusetts Prescription Awareness Tool (MassPAT) before writing a Schedule II 
or III opioid prescription. 
The state also launched first-in-the-nation core competencies requiring students 
graduating from the state’s medical, dental, nursing, and social work schools to 
receive training to prevent and treat substance misuse. 
 
In addition, the state has added more than 600 adult substance use disorder 
treatment beds since January 2015 and widely expanded the availability of naloxone, 
the overdose reversal drug.  
 For more information on the Commonwealth’s response to the opioid epidemic as 
well as links to the latest data, visit www.mass.gov/opioidresponse. To get help for a 
substance use disorder, visit www.helplinema.org, or call the Massachusetts 
Substance Use Helpline at 800-327-5050. 
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